leachman lab banner

Publications

View results from PubMed

adobe-pdf-logo

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology.
Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea J, Lim SJ, Cochran AJ, Meyskens FL.
Cancer Prev Res (Phila). 2014 Mar 10.

adobe-pdf-logo

Melanocytes as Instigators and Victims of Oxidative Stress.
Denat L, Kadekaro AL, Marrot L, Leachman SA, Abdel-Malek ZA.
J Invest Dermatol. 2014 Feb 27.

Isolation of circulating microRNAs from microvesicles found in human plasma.
Quackenbush JF, Cassidy PB, Pfeffer LM, Boucher KM, Hawkes JE, Pfeffer SR, Kopelovich L, Leachman SA.
Methods Mol Biol. 2014;1102:641-53.

adobe-pdf-logo

Perceived Risk Following Melanoma Genetic Testing: A 2-Year Prospective Study Distinguishing Subjective Estimates from Recall.Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA.
J Genet Couns. 2013 Dec 10.

adobe-pdf-logo

Acrylic nail curing UV lamps: high-intensity exposure warrants further research of skin cancer risk.
Curtis J, Tanner P, Judd C, Childs B, Hull C, Leachman S.
J Am Acad Dermatol. 2013 Dec;69(6):1069-70. Letter to the editor.

adobe-pdf-logo

Partner involvement in conduct of skin self-examinations remains low following CDKN2A/p16 genetic test reporting and counseling.
Taber JM, Aspinwall LG, Leaf SL, Kohlmann W, Leachman SA.
J Am Acad Dermatol. 2013 Nov;69(5):842-4. Letter to the editor.

adobe-pdf-logo

Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA.
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1687-97.

adobe-pdf-logo

Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi.Hawkes JE, Campbell J, Garvin D, Cannon-Albright L, Cassidy P, Leachman SA.
Front Oncol. 2013 Jun 28;3:160.

adobe-pdf-logo

Selenium for the prevention of cutaneous melanoma.
Cassidy PB, Fain HD, Cassidy JP Jr, Tran SM, Moos PJ, Boucher KM, Gerads R, Florell SR, Grossman D, Leachman SA.
Nutrients. 2013 Mar 7;5(3):725-49.

Sentinel lymph node biopsy for melanoma in pregnant women.
Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, Grossman D, Anker C, Florell SR, Bowen A, Duffy KL, Leachman SA, Noyes RD.
Ann Surg Oncol. 2013 Feb;20(2):689-96.

adobe-pdf-logo

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA.
Psychooncology. 2013 Feb;22(2):276-89.

adobe-pdf-logo

Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.
Hawkes JE, Cassidy PB, Manga P, Boissy RE, Goldgar D, Cannon-Albright L, Florell SR, Leachman SA.
J Dermatol Sci. 2013 Jan;69(1):30-7.

adobe-pdf-logo

Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.
Cannon-Albright LA, Teerlink CC, Farnham JM, Thomas AW, Zone JJ, Leachman SA.
J Invest Dermatol. 2013 Jan;133(1):128-34.

adobe-pdf-logo

Melanoma mimic: a case of multiple pagetoid Spitz nevi.Harris K, Florell SR, Papenfuss J, Kohlmann W, Jahromi M, Schiffman JD, Quackenbush J, Cassidy P, Leachman S.
Arch Dermatol. 2012 Mar;148(3):370-4.

adobe-pdf-logo

A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q.
Teerlink C, Farnham J, Allen-Brady K, Camp NJ, Thomas A, Leachman S, Cannon-Albright L.
Hum Genet. 2012 Jan;131(1):77-85.

adobe-pdf-logo

Individualizing follow-up for patients with early-stage melanoma.
Sondak VK, Leachman SA.
J Clin Oncol. 2011 Dec 10;29(35):4606-8.

adobe-pdf-logo

Parental preferences for CDKN2A/p16 testing of minors.
Taber JM, Aspinwall LG, Kohlmann W, Dow R, Leachman SA.
Genet Med. 2010 Dec;12(12):823-38.

adobe-pdf-logo

Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation.Kadekaro AL, Leachman S, Kavanagh RJ, Swope V, Cassidy P, Supp D, Sartor M, Schwemberger S, Babcock G, Wakamatsu K, Ito S, Koshoffer A, Boissy RE, Manga P, Sturm RA, Abdel-Malek ZA.
FASEB J. 2010 Oct;24(10):3850-60.

adobe-pdf-logo

The nuclear matrix shell proteome of human epidermis.Warters RL, Cassidy PB, Sunseri JA, Parsawar K, Zhuplatov SB, Kramer GF, Leachman SA.
J Dermatol Sci. 2010 May;58(2):113-22.

adobe-pdf-logo

Selection criteria for genetic assessment of patients with familial melanoma.Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarrà G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H.
J Am Acad Dermatol. 2009 Oct;61(4):677.e1-14. Review.

These publications can be downloaded for personal use and are not intended for redistribution.